Publication

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Journal Paper/Review - Aug 19, 2024

Units
PubMed
Doi
Contact

Citation
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai S, Zilioli V, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri A, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A, Janikova A, Cwynarski K, Mikhaeel G, Jerkeman M, Di Rocco A, Stepanishyna Y, Vitolo U, Santoro A, Re A, Puccini B, Olivieri J, Petrucci L, Barrington S, Malkowski B, Metser U, Versari A, Chauvie S, Walewski J, Trneny M, Cavalli F, Gospodarowicz M, Johnson P, Davies A, Zucca E, International Extranodal Lymphoma Study Group (IELSG), Hitz F. Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. J Clin Oncol 2024; 42:4071-4083.
Type
Journal Paper/Review (English)
Journal
J Clin Oncol 2024; 42
Publication Date
Aug 19, 2024
Issn Electronic
1527-7755
Pages
4071-4083
Brief description/objective

The role of consolidation radiotherapy in patients with primary mediastinal B-cell lymphoma (PMBCL) is controversial.